Akisato Y et al. |
[Effect of pitavastatin on macrophage cholesterol metabolism]. |
2008 |
Yakugaku Zasshi |
pmid:18311054
|
Iguchi K |
[Effect of bisphosphonates on anticancer activity in prostate cancer cells]. |
2012 |
Yakugaku Zasshi |
pmid:23023419
|
Tokoro T et al. |
The novel HMG-CoA reductase inhibitor, Pitavastatin, induces a protective action in vascular endothelial cells through the production of nitric oxide (NO). |
2004 |
Yakugaku Zasshi |
pmid:15049129
|
Rad SA et al. |
Type 2 IDI performs better than type 1 for improving lycopene production in metabolically engineered E. coli strains. |
2012 |
World J. Microbiol. Biotechnol. |
pmid:22806807
|
Targett-Adams P et al. |
Lipid metabolism and HCV infection. |
2010 |
Viruses |
pmid:21994676
|
Delang L et al. |
Antiviral therapy for hepatitis C virus: beyond the standard of care. |
2010 |
Viruses |
pmid:21994657
|
Sidorkiewicz M et al. |
Mevalonate pathway modulation is associated with hepatitis C virus RNA presence in peripheral blood mononuclear cells. |
2009 |
Virus Res. |
pmid:19540284
|
Rothwell C et al. |
Cholesterol biosynthesis modulation regulates dengue viral replication. |
2009 |
Virology |
pmid:19419745
|
Lin YL et al. |
Cholesterol requirement of hepatitis B surface antigen (HBsAg) secretion. |
2003 |
Virology |
pmid:14517078
|
Lyles DS et al. |
An alteration in the kinetic properties of a cholesterogenic enzyme in fowlpox virus infection. |
1975 |
Virology |
pmid:237362
|